betamethasone dipropionate 0.643 MG/ML / calcipotriene 0.05 MG/ML Topical Suspension [Attero]
RxNorm concept 2747392, branded drug (sbd). Prescribable name: ATTERO 0.064 % / 0.005 % Topical Suspension.
- RxCUI
- 2747392
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2747392 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Attero (betamethasone dipropionate 0.064 % / calcipotriene 0.005 % ) Topical Suspension
Related concepts
- calcipotriene 0.05 MG/ML (SCDC, consists of)
- betamethasone dipropionate 0.643 MG/ML (SCDC, consists of)
- betamethasone dipropionate 0.643 MG/ML / calcipotriene 0.05 MG/ML [Attero] (SBDC, consists of)
- Topical Suspension (DF, has dose form)
- Attero (BN, has ingredient)
- betamethasone dipropionate 0.643 MG/ML / calcipotriene 0.05 MG/ML Topical Suspension (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2747392 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2747392 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2747392. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.